Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Virus Res ; 190: 97-103, 2014 Sep 22.
Article in English | MEDLINE | ID: mdl-25018023

ABSTRACT

We have previously shown that human herpesvirus 8 (HHV-8) uses DC-SIGN as an entry receptor for dendritic cells, macrophages and B cells. The viral attachment protein for DC-SIGN is unknown. HHV-8 virions contain five conserved herpesvirus glycoproteins, a single unique glycoprotein, and two predicted glycoproteins. Previous studies have shown that DC-SIGN binds highly mannosylated glycoproteins. The HHV-8 glycoprotein B (gB) has been reported to be highly mannosylated, and therefore we hypothesized that gB will bind to DC-SIGN. In this report we confirm that gB has a high mannose carbohydrate structure and demonstrate for the first time that it binds DC-SIGN in a dose-dependent manner. We also identify key amino acids in the DC-SIGN carbohydrate recognition domain that are required for HHV-8 infection and compare these results with published binding regions for ICAM-2/3 and HIV-1 gp120. These results clarify some of the initial events in HHV-8 entry and can be used for the design of targeted preventive therapies.


Subject(s)
Cell Adhesion Molecules/metabolism , Herpesviridae Infections/metabolism , Herpesvirus 8, Human/metabolism , Lectins, C-Type/metabolism , Receptors, Cell Surface/metabolism , Receptors, Virus/metabolism , Viral Envelope Proteins/metabolism , Cell Adhesion Molecules/chemistry , Cell Adhesion Molecules/genetics , Herpesviridae Infections/genetics , Herpesviridae Infections/virology , Herpesvirus 8, Human/chemistry , Herpesvirus 8, Human/genetics , Humans , Lectins, C-Type/chemistry , Lectins, C-Type/genetics , Protein Binding , Protein Structure, Tertiary , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/genetics , Receptors, Virus/chemistry , Receptors, Virus/genetics , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics
2.
PLoS One ; 8(1): e54010, 2013.
Article in English | MEDLINE | ID: mdl-23308294

ABSTRACT

Infection of human B cells with wild-type Epstein-Barr virus (EBV) in vitro leads to activation and proliferation that result in efficient production of lymphoblastoid cell lines (LCLs). Latent Membrane Protein 2 (LMP2) is expressed early after infection and previous research has suggested a possible role in this process. Therefore, we generated recombinant EBV with knockouts of either or both protein isoforms, LMP2A and LMP2B (Δ2A, Δ2B, Δ2A/Δ2B) to study the effect of LMP2 in early B cell infection. Infection of B cells with Δ2A and Δ2A/Δ2B viruses led to a marked decrease in activation and proliferation relative to wild-type (wt) viruses, and resulted in higher percentages of apoptotic B cells. Δ2B virus infection showed activation levels comparable to wt, but fewer numbers of proliferating B cells. Early B cell infection with wt, Δ2A and Δ2B viruses did not result in changes in latent gene expression, with the exception of elevated LMP2B transcript in Δ2A virus infection. Infection with Δ2A and Δ2B viruses did not affect viral latency, determined by changes in LMP1/Zebra expression following BCR stimulation. However, BCR stimulation of Δ2A/Δ2B cells resulted in decreased LMP1 expression, which suggests loss of stability in viral latency. Long-term outgrowth assays revealed that LMP2A, but not LMP2B, is critical for efficient long-term growth of B cells in vitro. The lowest levels of activation, proliferation, and LCL formation were observed when both isoforms were deleted. These results suggest that LMP2A appears to be critical for efficient activation, proliferation and survival of EBV-infected B cells at early times after infection, which impacts the efficient long-term growth of B cells in culture. In contrast, LMP2B did not appear to play a significant role in these processes, and long-term growth of infected B cells was not affected by the absence of this protein.


Subject(s)
B-Lymphocytes/virology , Cell Survival/genetics , Herpesvirus 4, Human/genetics , RNA, Messenger/genetics , RNA, Viral/genetics , Viral Matrix Proteins/genetics , Apoptosis , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , Cell Proliferation , Cell Transformation, Viral , Gene Expression Regulation, Viral/genetics , Gene Knockout Techniques , HEK293 Cells , Herpesvirus 4, Human/metabolism , Humans , Kinetics , Lymphocyte Activation , RNA, Messenger/metabolism , RNA, Viral/metabolism , Time Factors , Trans-Activators/genetics , Trans-Activators/metabolism , Viral Matrix Proteins/deficiency , Virus Latency
SELECTION OF CITATIONS
SEARCH DETAIL
...